BAJAJ BROKING

Notification
No new Notification messages
Vishal Mega Mart IPO is Open!
Apply for the Vishal Mega Mart IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
NSE BSE
ishita drugs & industries ltd. stock

ISHITA DRUGS & INDUSTRIES LTD. Share Price

88.95 2.08 (2.39%)
Dec 12 2024 03:23 PM Pharmaceuticals NSE: ISHITADR

ISHITA DRUGS & INDUSTRIES LTD. Share Price Update

As of the latest trading session, ISHITA DRUGS & INDUSTRIES LTD. share price is currently at 88.95, which is up by 2.08 from its previous closing. Today, the stock has fluctuated between 86.51 and 88.95. Over the past year, ISHITA DRUGS & INDUSTRIES LTD. has achieved a return of 5.70 %. In the last month alone, the return has been 9.97 %. Read More...

ISHITA DRUGS & INDUSTRIES LTD. Performance

Day Range

Low86.51 High88.95
88.95

52 Week Range

Low 56.00 High 104.75
88.95

ISHITA DRUGS & INDUSTRIES LTD. Share Price

524400

ISHITADR

img img img img
No Data Available

Open Price

86.86

Prev. Close

86.86

Volume (Shares)

3559.00

Total traded value

3.11

Upper Circuit

.00

Lower Circuit

.00

Note: The current prices & values are delayed, Login to your account for live updates.

ISHITA DRUGS & INDUSTRIES LTD. Fundamentals


(Standalone)

Market Cap (Cr) 26.60
PE Ratio (TTM) 35.72
Book Value / Share 34.32
Beta 0.55
ROE 7.86%
EPS (TTM) 2.49
Dividend Yield 0.00%
Net Profit Qtr (Cr) 0.19

ISHITA DRUGS & INDUSTRIES LTD. Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars SEP 2024 (Values in Cr)
Revenue 3.27
Operating Expense 3.06
Net Profit 0.19
Net Profit Margin (%) 5.81
Earnings Per Share (EPS) 0.65
EBITDA 0.29
Effective Tax Rate (%) 23.07
Particulars JUN 2024 (Values in Cr)
Revenue 3.03
Operating Expense 2.88
Net Profit 0.15
Net Profit Margin (%) 4.95
Earnings Per Share (EPS) 0.49
EBITDA 0.24
Effective Tax Rate (%) 25.00
Particulars MAR 2024 (Values in Cr)
Revenue 4.50
Operating Expense 4.22
Net Profit 0.28
Net Profit Margin (%) 6.22
Earnings Per Share (EPS) 0.94
EBITDA 0.40
Effective Tax Rate (%) 24.32
Particulars DEC 2023 (Values in Cr)
Revenue 3.21
Operating Expense 3.06
Net Profit 0.12
Net Profit Margin (%) 3.73
Earnings Per Share (EPS) 0.40
EBITDA 0.23
Effective Tax Rate (%) 25.00
Particulars SEP 2023 (Values in Cr)
Revenue 4.40
Operating Expense 4.22
Net Profit 0.21
Net Profit Margin (%) 4.77
Earnings Per Share (EPS) 0.70
EBITDA 0.32
Effective Tax Rate (%) 25.00
Particulars MAR 2024 (Values in Cr)
Revenue 15.19
Operating Expense 14.48
Net Profit 0.75
Net Profit Margin (%) 4.93
Earnings Per Share (EPS) 2.50
EBITDA 1.19
Effective Tax Rate (%) 24.24
Particulars MAR 2023 (Values in Cr)
Revenue 12.07
Operating Expense 11.49
Net Profit 0.58
Net Profit Margin (%) 4.80
Earnings Per Share (EPS) 1.93
EBITDA 0.96
Effective Tax Rate (%) 25.64
Particulars MAR 2022 (Values in Cr)
Revenue 14.09
Operating Expense 13.15
Net Profit 0.81
Net Profit Margin (%) 5.74
Earnings Per Share (EPS) 2.69
EBITDA 1.19
Effective Tax Rate (%) 23.07
Particulars MAR 2021 (Values in Cr)
Revenue 13.95
Operating Expense 13.20
Net Profit 0.83
Net Profit Margin (%) 5.94
Earnings Per Share (EPS) 2.77
EBITDA 1.23
Effective Tax Rate (%) 20.95
Particulars MAR 2020 (Values in Cr)
Revenue 14.83
Operating Expense 14.28
Net Profit 0.55
Net Profit Margin (%) 3.70
Earnings Per Share (EPS) 1.83
EBITDA 0.91
Effective Tax Rate (%) 23.94
Particulars MAR 2024 (Values in Cr)
Book Value / Share 33.18
ROE % 7.86
ROCE % 10.77
Total Debt to Total Equity 0.05
EBITDA Margin 7.83
Particulars MAR 2023 (Values in Cr)
Book Value / Share 30.68
ROE % 6.53
ROCE % 8.86
Total Debt to Total Equity 0.05
EBITDA Margin 7.95
Particulars MAR 2022 (Values in Cr)
Book Value / Share 28.75
ROE % 9.76
ROCE % 12.90
Total Debt to Total Equity 0.00
EBITDA Margin 8.45
Particulars MAR 2021 (Values in Cr)
Book Value / Share 26.05
ROE % 11.25
ROCE % 14.32
Total Debt to Total Equity 0.02
EBITDA Margin 8.82
Particulars MAR 2020 (Values in Cr)
Book Value / Share 23.28
ROE % 8.23
ROCE % 10.82
Total Debt to Total Equity 0.04
EBITDA Margin 6.20
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 4.80
Total Assets 10.80
Total Liabilities 10.80
Total Equity 9.92
Share Outstanding 2990300
Price to Book Ratio 1.98
Return on Assets (%) 6.92
Return on Capital (%) 7.54
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 3.42
Total Assets 11.40
Total Liabilities 11.40
Total Equity 9.17
Share Outstanding 2990300
Price to Book Ratio 1.61
Return on Assets (%) 5.06
Return on Capital (%) 5.7
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 4.68
Total Assets 11.25
Total Liabilities 11.25
Total Equity 8.59
Share Outstanding 2990300
Price to Book Ratio 1.44
Return on Assets (%) 7.15
Return on Capital (%) 9.36
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 2.53
Total Assets 9.26
Total Liabilities 9.26
Total Equity 7.79
Share Outstanding 2990300
Price to Book Ratio 1.15
Return on Assets (%) 8.95
Return on Capital (%) 10.65
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 0.99
Total Assets 9.54
Total Liabilities 9.54
Total Equity 6.96
Share Outstanding 2990300
Price to Book Ratio 0.47
Return on Assets (%) 5.73
Return on Capital (%) 7.63
Particulars MAR 2024 (Values in Cr)
Net Income 0.98
Cash from Operations 2.12
Cash from Investing 0.13
Cash from Financing -0.86
Net change in Cash 1.38
Free Cash Flow 2.14
Particulars MAR 2023 (Values in Cr)
Net Income 0.77
Cash from Operations -2.89
Cash from Investing 0.59
Cash from Financing 1.04
Net change in Cash -1.25
Free Cash Flow -2.76
Particulars MAR 2022 (Values in Cr)
Net Income 1.04
Cash from Operations 3.07
Cash from Investing -0.93
Cash from Financing 0.00
Net change in Cash 2.14
Free Cash Flow 3.09
Particulars MAR 2021 (Values in Cr)
Net Income 1.05
Cash from Operations -0.67
Cash from Investing 2.45
Cash from Financing -0.23
Net change in Cash 1.53
Free Cash Flow -0.66
Particulars MAR 2020 (Values in Cr)
Net Income 0.71
Cash from Operations 1.04
Cash from Investing -1.15
Cash from Financing 0.09
Net change in Cash -0.01
Free Cash Flow 1.06
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 65.16 37.45 3.55 499.34 37.54 / 77.70
BLISS GVS PHARMA LTD 151.80 19.00 1.58 1598.94 92.25 / 172.40
CIPLA LTD 1454.20 25.44 4.14 117443.01 1192.85 / 1702.00
FERMENTA BIOTECH LIMITED 410.00 142.36 4.15 1206.67 145.00 / 440.00
GLAXOSMITHKLINE PHARMA LT 2345.45 49.56 23.75 39733.34 1664.75 / 3087.95
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 65.16 56.66 11.07 499.34 37.54 / 77.70
AMRUTAJAN HEALTH LTD 749.55 45.59 7.27 2167.00 556.05 / 861.40
ASTRAZENECA PHARMA IND LT 6595.05 128.08 24.26 16487.63 4050.15 / 8139.85
BLISS GVS PHARMA LTD 151.80 19.79 1.56 1598.94 92.25 / 172.40

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 88.80
  • 26 Days 84.70
  • 10 Days 89.00
  • 50 Days 82.60
  • 12 Days 88.80
  • 100 Days 80.50
  • 20 Days 85.80
  • 200 Days 78.90
87.65
PIVOT
First Resistance 88.86
Second Resistance 90.85
Third Resistance 92.06
First Support 85.66
Second Support 84.45
Third Support 82.46
RSI 54.45
MACD 4.10
Commodity Channel Index (CCI) 41.07
ADX 6.70
Williams % R -27.25

Over 1 Month

down

9.97

Over 3 Months

down

8.19

Over 6 Months

down

29.64

Over 1 Year

down

5.70

Over 3 Years

down

26.65

Over 5 Years

down

48.89

ISHITA DRUGS & INDUSTRIES LTD. Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

ISHITA DRUGS & INDUSTRIES LTD. Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Public
50.19
Promoter Holdings
49.8
FII
0.0
DII
0.0
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Umang Financial Services Limited Shareholding of Promoter and Promoter Group 297300.0 9.94
Abha Agrawal Shareholding of Promoter and Promoter Group 250296.0 8.37
Sumit Agrawal Shareholding of Promoter and Promoter Group 231969.0 7.76
Shri Jagdish Agrawal Shareholding of Promoter and Promoter Group 175259.0 5.86
Ishita Overseas Private Limited Shareholding of Promoter and Promoter Group 130000.0 4.35
Divya Sumit Agrawal Shareholding of Promoter and Promoter Group 104150.0 3.48
Krishn Sumit Agrawal Shareholding of Promoter and Promoter Group 90000.0 3.01
Agrawal Jagdishprasad G Shareholding of Promoter and Promoter Group 85000.0 2.84
Sumit Agrawal Shareholding of Promoter and Promoter Group 60000.0 2.01
Patel Bhupesh Vahalabhai Public Shareholding 55000.0 1.84
Mahendra Girdharilal Wadhwani Public Shareholding 40917.0 1.37
Vikkramm Chandirramani Public Shareholding 40283.0 1.35
Varlika Sumit Agrawal Shareholding of Promoter and Promoter Group 40000.0 1.34
Sangeetha S Public Shareholding 38000.0 1.27
Ishita Agrawal Shareholding of Promoter and Promoter Group 25140.0 0.84
Virendra Kumar Agrawal Shareholding of Promoter and Promoter Group 100.0 0.0

ISHITA DRUGS & INDUSTRIES LTD.

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date

Learn More About Stocks

About ISHITA DRUGS & INDUSTRIES LTD.

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by ISHITA DRUGS & INDUSTRIES LTD.

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Ishita Drugs & Industries Ltd?

Answer Field

The share price of Ishita Drugs & Industries Ltd for NSE is ₹ 0.00 and for BSE is ₹ 88.95.

What is the Market Cap of Ishita Drugs & Industries Ltd?

Answer Field

The market cap of Ishita Drugs & Industries Ltd for NSE is ₹ 0.0 Cr. and for BSE is ₹ 26.60 Cr. as of now.

What is the 52 Week High and Low of Ishita Drugs & Industries Ltd?

Answer Field

The 52 Week High and Low of Ishita Drugs & Industries Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 104.75 and ₹ 56.00.

How to Buy Ishita Drugs & Industries Ltd share?

Answer Field

You can trade in Ishita Drugs & Industries Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Ishita Drugs & Industries Ltd?

Answer Field

The 1 year returns on the stock has been 5.70%.

What is the Current Share Price of Ishita Drugs & Industries Ltd?

Answer Field

Ishita Drugs & Industries Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 88.95 as on Dec 12 2024 03:23 PM.

What is the Market Cap of Ishita Drugs & Industries Ltd Share?

Answer Field

The market cap of Ishita Drugs & Industries Ltd for NSE ₹ 0.0 & for BSE ₹ 26.60 as on Dec 12 2024 03:23 PM.

What is the P/E Ratio of Ishita Drugs & Industries Ltd Share?

Answer Field

As on Dec 12 2024 03:23 PM the price-to-earnings (PE) ratio for Ishita Drugs & Industries Ltd share is 35.72.

What is the PB ratio of Ishita Drugs & Industries Ltd Share?

Answer Field

As on Dec 12 2024 03:23 PM, the price-to-book (PB) ratio for Ishita Drugs & Industries Ltd share is 34.32.

How to Buy Ishita Drugs & Industries Ltd Share?

Answer Field

You can trade in Ishita Drugs & Industries Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Ishita Drugs & Industries Ltd Share on Bajaj Broking App?

Answer Field

To buy Ishita Drugs & Industries Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Ishita Drugs & Industries Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

8 Lacs+ Users

icon-with-text

4.4+ App Rating

icon-with-text

4 Languages

icon-with-text

₹4700+ Cr MTF Book

icon-with-text
loader